SAIPARENT

Healthcare Drug Manufacturers - General

★ Watchlist ⧉ Add to bucket

₹518.05

-0.18% today · 30d -4.06%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for SAIPARENT. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹179 Cr

NET PROFIT

₹8 Cr

OPM

14.94%

EPS

₹1.79

PE 115.54

Intrinsic value · DCF ₹1609.42 · Margin of safety +210.7% (undervalued) · FCF yield 3.26%

◇ Sector Position

PEERPEROCE %

SAIPARENT115.54—

GLAXO46.8657.97

RUBICON101.0127.36

PFIZER28.6424.29

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance — —

Valuation STRETCHED 5

Growth STEADY 58

Profitability DECENT 55

Technicals WEAK 37

Risk LOW 80

Key Stats

TTM PE

115.54

P/B

3.44

52W HIGH

₹706.0

OFF HIGH

-26.62%

MKT CAP

₹2292 Cr

◉ Active Signals

MACDBearish-1.5456

RSI(14)Neutral40.43

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SAIPARENT and at what entry.